Fertility and Sterility
Volume 90, Issue 4 , Pages 965-971, October 2008

Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy

  • Kavita Nanda, M.D., M.H.S.

      Affiliations

    • Family Health International, Research Triangle Park, North Carolina
    • Corresponding Author InformationReprint requests: Kavita Nanda, M.D., M.H.S., Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709 (FAX: 919-544-7261).
  • ,
  • Eliana Amaral, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas, Campinas, Brazil
  • ,
  • Melissa Hays, M.P.H.

      Affiliations

    • Family Health International, Research Triangle Park, North Carolina
  • ,
  • Marco A.M. Viscola, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas, Campinas, Brazil
  • ,
  • Neha Mehta, M.P.H.

      Affiliations

    • Family Health International, Research Triangle Park, North Carolina
  • ,
  • Luis Bahamondes, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas, Campinas, Brazil

Received 26 February 2007; received in revised form 16 July 2007; accepted 18 July 2007. published online 19 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Support for this work was provided by funds from the United States Agency for International Development (USAID) (cooperative agreements nos. AID/CCP-3079-A-00-5022-00 and GPO-A-OO-05-00022-00), the Contraceptive and Reproductive Health Technologies Research and Utilization Program, and the University of North Carolina at Chapel Hill Center for AIDS Research (a National Institutes of Health-funded program; P30 AI50410). The views expressed in this document, however, do not necessarily reflect those of USAID.

PII: S0015-0282(07)02999-8

doi:10.1016/j.fertnstert.2007.07.1348

Fertility and Sterility
Volume 90, Issue 4 , Pages 965-971, October 2008